$ONMD

Green Aaron purchased $31K of ONMD

Green Aaron (Chief Executive Officer) purchased 55,622 shares of OneMedNet Corp (ONMD) at an average of $0.55 ($0.54–$0.56) across 2 trades over 2026-06-12 to 2026-06-15.

Original reporting
SEC EDGAR · Green Aaron
Published Jun 16, 2026, 10:04 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 10:06 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ONMD
Bullish
medium confidence
Mentioned
$ONMD
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ONMDBullishLow
01

Why it matters

The CEO’s open-market purchase may be interpreted as confidence, but without accompanying company-specific fundamentals (earnings, trial data, contracts), it is unlikely to materially reprice the stock by itself.

02

Market read

Traders may treat this as a small sentiment input, but it does not introduce new operating or financial information.

03

What to watch

The article provides no follow-on guidance, financial results, or operational catalyst—only the Form 4 details and post-transaction share count.

Relevance 4/10Novelty 6/10Timing: Filed on 2026-06-16 (transactions dated 2026-06-12 to 2026-06-15).

Background

The article is an SEC Form 4 insider transaction disclosure for OneMedNet (ONMD).

Company-level read

Ticker impact

$ONMDBullishMedium confidence
Context

OneMedNet CEO Green Aaron filed an open-market purchase of 55,622 shares at ~$0.552 weighted average via SEC Form 4.

Expected impact

Likely limited near-term price impact; may slightly support sentiment rather than drive a trend.

Evidence & confidence

The filing is primary-source and directly about ONMD, but the transaction size/value (~$30.7K) and lack of 10b5-1 context reduce materiality for fundamentals.

Market effects

No clear sector read-through; this is a single-company insider transaction.

None indicated.

None indicated.

Counterpoint

Insider buys can be driven by personal liquidity needs or routine compensation/portfolio rebalancing, so the signal may be weak.

Key entities

  • OneMedNet Corp

    Subject of the SEC Form 4 insider transaction disclosure.

  • Green Aaron

    CEO and officer/director who purchased ONMD shares in open-market trades.

Related articles